Betaferon Regulatory Post-Marketing Surveillance

Trial Profile

Betaferon Regulatory Post-Marketing Surveillance

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Oct 2014

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Bayer
  • Most Recent Events

    • 16 Aug 2012 Additional location [South Korea] identified as reported by ClinicalTrials.gov.
    • 16 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top